These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

205 related articles for article (PubMed ID: 26936942)

  • 41. Use of alternatives to estrogen for treatment of menopause.
    Pinkerton JV; Santen R
    Minerva Endocrinol; 2002 Mar; 27(1):21-41. PubMed ID: 11845111
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Hormone replacement therapy and beyond. The clinical challenge of menopausal symptoms in breast cancer survivors.
    Mortimer JE
    Geriatrics; 2002 Sep; 57(9):25-31. PubMed ID: 12271826
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Advances in the treatment of menopausal symptoms.
    Pinkerton JV; Stovall DW; Kightlinger RS
    Womens Health (Lond); 2009 Jul; 5(4):361-384; quiz 383-4. PubMed ID: 19586429
    [TBL] [Abstract][Full Text] [Related]  

  • 44. An overview of menopause associated vasomotor symptoms and options available in its management.
    Okeke TC; Ezenyeaku CC; Ikeako LC; Agu PU
    Niger J Med; 2013; 22(1):7-14. PubMed ID: 23441513
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Menopausal symptoms.
    Bouts BA
    N Engl J Med; 2007 Mar; 356(11):1176-7; author reply 1177-8. PubMed ID: 17361001
    [No Abstract]   [Full Text] [Related]  

  • 46. Ultra-low dose - new approaches in menopausal hormone therapy.
    Stute P; Becker HG; Bitzer J; Chatsiproios D; Luzuy F; von Wolff M; Wunder D; Birkhäuser M
    Climacteric; 2015 Apr; 18(2):182-6. PubMed ID: 25335192
    [TBL] [Abstract][Full Text] [Related]  

  • 47. A large multinational study of vasomotor symptom prevalence, duration, and impact on quality of life in middle-aged women.
    Blümel JE; Chedraui P; Baron G; Belzares E; Bencosme A; Calle A; Danckers L; Espinoza MT; Flores D; Gomez G; Hernandez-Bueno JA; Izaguirre H; Leon-Leon P; Lima S; Mezones-Holguin E; Monterrosa A; Mostajo D; Navarro D; Ojeda E; Onatra W; Royer M; Soto E; Tserotas K; Vallejo S;
    Menopause; 2011 Jul; 18(7):778-85. PubMed ID: 21407137
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Use of gabapentin in patients experiencing hot flashes.
    Brown JN; Wright BR
    Pharmacotherapy; 2009 Jan; 29(1):74-81. PubMed ID: 19113798
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Non-hormonal treatments for menopausal symptoms.
    Hickey M; Saunders CM; Stuckey BG
    Maturitas; 2007 May; 57(1):85-9. PubMed ID: 17367965
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Treatment of menopausal symptoms.
    Tong IL
    Compr Ther; 2008; 34(1):41-7. PubMed ID: 18681111
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Current management of menopausal symptoms in cancer patients.
    Barton DL; Loprinzi C; Gostout B
    Oncology (Williston Park); 2002 Jan; 16(1):67-72, 74; discussion 75-6, 79-80. PubMed ID: 11831612
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Management of menopause in women with breast cancer.
    Vincent AJ
    Climacteric; 2015 Oct; 18(5):690-701. PubMed ID: 25536007
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Nonhormonal alternatives to treating menopausal symptoms.
    Cass I; Runowicz CD
    Am J Manag Care; 1998 May; 4(5):732-8; quiz 739-40. PubMed ID: 10179926
    [No Abstract]   [Full Text] [Related]  

  • 54. Hot flashes and androgens: a biological rationale for clinical practice.
    Notelovitz M
    Mayo Clin Proc; 2004 Apr; 79(4 Suppl):S8-13. PubMed ID: 15065632
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Alternative therapies for traditional disease states: menopause.
    Morelli V; Naquin C
    Am Fam Physician; 2002 Jul; 66(1):129-34. PubMed ID: 12126027
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Vasomotor symptoms in menopause: where we've been and where we're going.
    Pinkerton JV; Zion AS
    J Womens Health (Larchmt); 2006 Mar; 15(2):135-45. PubMed ID: 16536677
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Treatment of menopausal vasomotor symptoms.
    Obstet Gynecol; 2005 May; 105(5 Pt 1):1137-9. PubMed ID: 15863558
    [No Abstract]   [Full Text] [Related]  

  • 58. Menopause-specific quality of life across varying menopausal populations with conjugated estrogens/bazedoxifene.
    Abraham L; Pinkerton JV; Messig M; Ryan KA; Komm BS; Mirkin S
    Maturitas; 2014 Jul; 78(3):212-8. PubMed ID: 24837362
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Management of menopausal symptoms in patients with breast cancer: an evidence-based approach.
    Hickey M; Saunders CM; Stuckey BG
    Lancet Oncol; 2005 Sep; 6(9):687-95. PubMed ID: 16129369
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Drugs for menopausal symptoms.
    Med Lett Drugs Ther; 2012 May; 54(1391):41-3. PubMed ID: 22643440
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 11.